Music Therapy in Obsessive Compulsive Disorder

December 10, 2014 updated by: Shahrzad Shirani, Islamic Azad University, Marvdasht

A Randomized Clinical Trial of Music Therapy as an Adjunct to Standard Treatment for Obsessive Compulsive Disorder and Co-morbid Anxiety and Depression in Iran

Previous studies have highlighted the potential therapeutic benefits of receptive individual music therapy as an adjunct to standard care, in a variety of psychiatric ailments including mood and anxiety disorders. However, the role of music in the treatment of obsessive compulsive disorder have not been investigated to date. The present study therefore aimed to investigate the efficacy of music therapy as an adjunct to standard treatment, on obsessions in patients with treatment-naïve OCD. Moreover, given the fact that a significant proportion of patients with OCD have other comorbid mood or anxiety disorders, the question of whether therapeutic benefits of music could be expanded to also affect concurrent depressive and anxiety symptoms was explored.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • were at least 18 years or older;
  • had axis I diagnosis of OCD according to the criteria delineated by the diagnostic and statistical manual of mental disorders - fourth edition diagnosed by an experienced psychiatrist
  • had not received treatment previously for the disorder
  • agreed to partake in the study

Exclusion Criteria:

  • refused to partake in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard treatment + music therapy
Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy. Music therapy encompassing 12 half-hour sessions of therapist-supervised receptive music therapy scheduled over four weeks
A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.
Other Names:
  • Pharmacotherapy
Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.
Other Names:
  • Psychotherapy
12 sessions of 30-minute individual-based receptive music therapy, supervised by the treating psychiatrist.
Other Names:
  • Receptive music therapy
Active Comparator: Standard treatment only
Selective serotonin re-uptake inhibitor plus cognitive behavioral therapy.
A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.
Other Names:
  • Pharmacotherapy
Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.
Other Names:
  • Psychotherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Obsession (Maudsley Obsessive-Compulsive Inventory)
Time Frame: 1 month
Post-intervention scores on Maudsley Obsessive-Compulsive Inventory
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Obsession subtype (Maudsley Obsessive-Compulsive Inventory sub-types)
Time Frame: 1 month
Post-intervention scores on Maudsley Obsessive-Compulsive Inventory sub-types
1 month
Anxiety symptoms (Beck Anxiety Inventory)
Time Frame: 1 month
Post-intervention scores on Beck Anxiety Inventory
1 month
Depressive symptoms (Beck Depression Inventory - Short Form)
Time Frame: 1 month
Post-intervention scores on Beck Depression Inventory - Short Form
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

August 1, 2014

Study Registration Dates

First Submitted

November 27, 2014

First Submitted That Met QC Criteria

December 10, 2014

First Posted (Estimate)

December 11, 2014

Study Record Updates

Last Update Posted (Estimate)

December 11, 2014

Last Update Submitted That Met QC Criteria

December 10, 2014

Last Verified

December 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Selective serotonin re-uptake inhibitor

3
Subscribe